Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 1/2021

01-01-2021 | Opioids | Concise Research Report

“I Don’t Mind Doing What It Takes to be Safe.” Patient Perspectives of Urine Drug Testing for Pain

Authors: Jessica Wyse, PhD, Akeesha Simmons, BA, Banu Ramachandran, JD, Steven K. Dobscha, MD, Benjamin J. Morasco, PhD

Published in: Journal of General Internal Medicine | Issue 1/2021

Login to get access

Excerpt

Urine drug testing (UDT) is a standard recommendation for those prescribed long-term opioid therapy (LTOT) for pain,1 but remains underutilized.2 Clinician fears regarding negative patient perceptions have been identified as a barrier to conducting UDT;3 however, little is known about patient perspectives of UDT. This study sought to uncover patients’ beliefs regarding UDT and its implications for the patient–clinician relationship. …
Literature
1.
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. Jama. 2016;315(15):1624–1645.CrossRef
2.
Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med 2011;26(9):958–964.CrossRef
3.
Krebs EE, Bergman AA, Coffing JM, Campbell SR, Frankel RM, Matthias MS. Barriers to guideline-concordant opioid management in primary care—a qualitative study. J Pain 2014;15(11):1148–1155.CrossRef
4.
Morasco BJ, Smith N, Dobscha SK, Deyo RA, Hyde S, Yarborough BJH. Outcomes of prescription opioid dose escalation for chronic pain: Results from a prospective cohort study. Pain (in press)
5.
Wyse JJ, Ganzini L, Dobscha SK, Krebs EE, Morasco BJ. Setting Expectations, Following Orders, Safety, and Standardization: Clinicians’ Strategies to Guide Difficult Conversations About Opioid Prescribing. J Gen Intern Med 2019:1–7.
Metadata
Title
“I Don’t Mind Doing What It Takes to be Safe.” Patient Perspectives of Urine Drug Testing for Pain
Authors
Jessica Wyse, PhD
Akeesha Simmons, BA
Banu Ramachandran, JD
Steven K. Dobscha, MD
Benjamin J. Morasco, PhD
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 1/2021
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05688-3

Other articles of this Issue 1/2021

Journal of General Internal Medicine 1/2021 Go to the issue

Concise Research Report

Out-of-Network Spending on Behavioral Health, 2008–2016

Viewpoint

The COVID-19 Pandemic and Ethical Challenges Posed by Neoliberal Healthcare

Original Research

Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network

Original Research

Assessing Utilization of the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Diagnosis of Neurosyphilis: a Cohort Study

Perspective

SGIM’s Endorsement of ACP’s Better Is Possible: Aligning Policy with Values

Concise Research Report

National Well-Being Measures Before and During the COVID-19 Pandemic in Online Samples
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits